Consultation on the Second Legislative Review of the Tobacco and Vaping Products Act
Current status: Open
Opened on September 7, 2023 and closes to new input on November 3, 2023 at 11:59 p.m. Eastern Standard Time (EST).
This consultation is seeking comments on the tobacco-related provisions and operation of the Tobacco and Vaping Products Act (TVPA).
This review, the second legislative review of the TVPA, will focus on the tobacco-related provisions and operation of the TVPA. Specifically, it will assess whether progress is being made towards achieving the tobacco-related objectives of the TVPA and whether the federal response, from a legislative perspective, is sufficient to address tobacco use in Canada. This review will serve to complement the first review on vaping products. Together, they will provide a baseline assessment of the TVPA.
Submissions will be summarized in a final report; however, comments will not be attributed to any specific individual or organization. This final report will be tabled in Parliament and will be made public on Canada.ca.
Join in: how to participate
A key part of the legislative review is seeking the perspectives of Canadians, experts, and other stakeholders as they relate to the operation of the TVPA, with a particular emphasis on the Act's ability to address tobacco use.
You are invited to participate in this consultation. To assist in providing your input, a discussion paper was prepared that includes a list of key questions. The list is not exhaustive and any input relating to tobacco regulation under the TVPA is welcome.
You are also encouraged to submit any evidence that you may have to support your responses.
The consultation period ends November 3, 2023.
You may participate by sending your written submission to: legislativereviewtvpa.revisionlegislativeltpv@hc-sc.gc.ca
You must declare any perceived or actual conflicts of interest with the tobacco industry when providing input to this consultation. If you are part of the tobacco industry, an affiliated organization or an individual acting on its behalf, you must clearly state so in your submission.
Health Canada is also interested in being made aware of perceived or actual conflicts of interest with the vaping and/or pharmaceutical industry. Therefore, please declare any perceived or actual conflicts of interest, if applicable, when providing input. If you are a member of the vaping and/or pharmaceutical industry, an affiliated organization or an individual acting on their behalf, you are asked to clearly state so in your submission.
Who is the focus of this consultation
We are seeking comments from:
- The general public, including those with lived and living experiences of tobacco use
- Indigenous peoples and organizations
- Provincial and Territorial governments
- Health partners
- Tobacco control experts - domestic and international
- Non-governmental organizations
- Academics
- Youth
- Interested members of the industry
Related information
Canada introduced new measures to regulate tobacco and vaping products and a new tobacco control strategy in 2018. The Tobacco Act of 1997 was amended and renamed the Tobacco and Vaping Products Act (TVPA) and Canada's Tobacco Strategy (CTS) was launched to address tobacco use in Canada. CTS sets an ambitious target to reduce the prevalence of tobacco use to less than 5 percent by 2035, to reduce the staggering death and disease burden of tobacco use.
To achieve this target, CTS aims to prioritize helping Canadians quit tobacco, protect youth and people who do not use tobacco from nicotine addiction, support Indigenous organizations to develop and implement self-led distinct approaches to reducing commercial tobacco use, and strengthen science, surveillance, and partnerships.
As an added safeguard, the TVPA includes a requirement to undertake a legislative review of its provisions and operation three years after coming-into-force, and every two years thereafter. The public consultation will help support the evidence-based analysis and review of the legislation.
Contact us
Manager, Legislative Review
Office of Policy and Strategic Planning
Tobacco Control Directorate
Controlled Substances and Cannabis Branch, Health Canada
0301A-150 Tunney's Pasture Driveway
Ottawa, ON K1A 0K9
Email: legislativereviewtvpa.revisionlegislativeltpv@hc-sc.gc.ca
Page details
- Date modified: